The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed FDA weighs easing rules on unapproved peptides embraced by RFK Jr pennlive.com Peptides for Plastic Surgery: Weight Loss, Skin, Healing & Recovery The peptide problem: Hype is outrunning the evidence Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law